Summary
The
leading business intelligence provider, has released its latest research,
"Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options
Enhanced As Novel Next Generation AEDs Show Improved Safety and
Tolerability", which provides in-depth analysis of epilepsy market within
the Asia-Pacific (APAC) market covering the four countries of Australia, China,
India and Japan. The report provides an estimation of market size for 2012,
along with market forecast until 2019. It also covers disease epidemiology,
treatment algorithms, treatment patterns, in-depth analysis of the pipeline,
and deal analysis.
Click Here For Complete Report @ http://www.radiantinsights.com/research/epilepsy-therapeutics-in-asia-pacific-markets-to-2019-treatment-options-enhanced-as-novel-next-generation-aeds-show-improved-safety-and-tolerability
The
value of the epilepsy market in the APAC region amounted to an estimated $1.1
billion in 2012 and is expected to register a Compound Annual Growth Rate
(CAGR) of 4.7% to reach $1.5 billion by 2019. The key drivers for growth in the
APAC market include: high prevalence in China and India, increased market
penetration due to improved market access in China and the expected approvals
of drugs with novel mechanisms of action which could expand the therapeutic
Scope. Conversely, the growth of the market in APAC region could face the
restricting influence of prescribing patterns that give preference to older
generation drugs and also due to generic competition as a result of key patent
expiries.
Download sample Copy of This Report at: www.radiantinsights.com/research/epilepsy-therapeutics-in-asia-pacific-markets-to-2019-treatment-options-enhanced-as-novel-next-generation-aeds-show-improved-safety-and-tolerability#tabs-4
Scope
The
report analyzes treatment usage patterns, market characterization, pipeline
analysis and key licensing and co-development deals in anti-epileptics in the
four APAC markets of Australia, China, India and Japan. The report includes -
-
A brief introduction to epilepsy, including disease pathogenesis, risk factors,
diagnosis and treatment options
-
In-depth analysis of major marketed products covering product performance,
product life-cycle and a heat map depicting comparative analysis of safety and
efficacy parameters
-
A comprehensive review of the epilepsy pipeline which includes individual
analysis of promising late-stage pipeline drugs that are likely to enter the
market during the forecast period. The pipeline is analyzed on the basis of
Phase distribution, molecule type and molecular target.
-
Additional clinical trial analysis by Phase, trial size, trial duration and
program failure rate for each molecule type and mechanism of action
-
Multi-scenario forecasts of the epilepsy market from 2012 to 2019 in the four
APAC regions
-
In-depth analysis of licensing and co-development agreements and an overview of
key agreements that could impact growth trends
-
Key drivers and restraints that have had and are expected to have a significant
impact upon the market
See More Reports of This Category
by Radiant Insights:
·
NeuroWave Systems Inc. - Product Pipeline Analysis,
2015 Update - http://www.radiantinsights.com/research/neurowave-systems-inc-product-pipeline-analysis-2015-update
·
Direct Flow Medical, Inc. - Product Pipeline
Analysis, 2015 Update - http://www.radiantinsights.com/research/direct-flow-medical-inc-product-pipeline-analysis-2015-update
Reasons to buy
The
report will enhance your decision-making capability by allowing you to -
-
Align your product portfolio to markets with high growth potential
-
Develop market entry and expansion strategies by identifying the potential
regions and therapeutic segments poised for strong growth
-
Devise effective, tailored strategies for each country through the
understanding of key drivers and barriers in the anti-epileptic drugs market
-
Develop key strategic initiatives based upon an understanding of key focus
areas and leading companies
-
Accelerate and strengthen your market position by identifying key companies for
mergers, acquisitions and strategic partnerships
About Radiant Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://www.radiantinsightsinc.blogspot.com
No comments:
Post a Comment